| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1177/070674370605101002 |
| P698 | PubMed publication ID | 17052030 |
| P50 | author | Jürgen Rehm | Q59708828 |
| P2093 | author name string | Benedikt Fischer | |
| Michelle Firestone Cruz | |||
| P2860 | cites work | The self-medication hypothesis of substance use disorders: a reconsideration and recent applications | Q28255574 |
| Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004 | Q28275343 | ||
| Major increases in opioid analgesic abuse in the United States: concerns and strategies | Q30241262 | ||
| Factors associated with frequent needle exchange program attendance in injection drug users in Vancouver, Canada | Q32115896 | ||
| Inhaled heroin-induced status asthmaticus: five cases and a review of the literature | Q33814712 | ||
| Fatal heroin overdoses resulting from non-injecting routes of administration, NSW, Australia, 1992-1996. | Q33903508 | ||
| Prescription opiate abuse in chronic pain patients: clinical criteria, incidence, and predictors | Q34429068 | ||
| Predictors of outcome in LAAM, buprenorphine, and methadone treatment for opioid dependence. | Q34478225 | ||
| Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users | Q34795051 | ||
| Heroin-assisted treatment as a response to the public health problem of opiate dependence. | Q34859986 | ||
| An Exploratory Study of Inhalers and Injectors Who Used Black Tar Heroin | Q34931401 | ||
| Assessment and treatment of comorbid psychiatric disorders in opioid-dependent patients | Q35024272 | ||
| Understanding polydrug use: review of heroin and cocaine co-use | Q35030844 | ||
| College on Problems of Drug Dependence taskforce on prescription opioid non-medical use and abuse: position statement | Q35084350 | ||
| Heroin overdose: research and evidence-based intervention | Q35147553 | ||
| Medical prescription of heroin to treatment resistant heroin addicts: two randomised controlled trials | Q35218513 | ||
| Prescription opioid abuse in patients presenting for methadone maintenance treatment | Q35630313 | ||
| Psychiatric comorbidity in opiate addicts. | Q51983545 | ||
| Self-reported overdose among injecting drug users in London: extent and nature of the problem. | Q52277773 | ||
| Transitions between routes of heroin administration: a study of Caucasian and Indochinese heroin users in south-western Sydney, Australia. | Q52277981 | ||
| Heroin snorters versus injectors: comparison on drug use and treatment outcome in age-matched samples. | Q52278715 | ||
| Trends in treated opiate misuse in Dublin: the emergence of chasing the dragon. | Q52279138 | ||
| Polydrug dependence and psychiatric comorbidity among heroin injectors. | Q53357261 | ||
| Prevalence, Correlates, and Comorbidity of DSM-IV Antisocial Personality Syndromes and Alcohol and Specific Drug Use Disorders in the United States | Q56484820 | ||
| Overdose among heroin users in Sydney, Australia: I. Prevalence and correlates of non-fatal overdose | Q59138938 | ||
| Eyes wide shut?--A conceptual and empirical critique of methadone maintenance treatment. | Q35988623 | ||
| Hepatitis C virus infection and injection drug users: prevention, risk factors, and treatment | Q36071310 | ||
| An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research | Q36144599 | ||
| Injection drug use and the hepatitis C virus: considerations for a targeted treatment approach--the case study of Canada | Q36272393 | ||
| Illicit opioid use in Canada: comparing social, health, and drug use characteristics of untreated users in five cities (OPICAN study). | Q36274331 | ||
| Beliefs about methadone in an inner-city methadone clinic | Q36274813 | ||
| Social costs of untreated opioid dependence | Q36274931 | ||
| Role of buprenorphine in the management of heroin addiction | Q36376715 | ||
| Determinants of overdose incidents among illicit opioid users in 5 Canadian cities | Q36988754 | ||
| Accidental fatal drug overdoses in New York City: 1990-1992. | Q39426381 | ||
| Comorbid depression among untreated illicit opiate users: results from a multisite Canadian study | Q39734970 | ||
| Methadone maintenance treatment: An update | Q40470835 | ||
| Role of maintenance treatment in opioid dependence | Q40826831 | ||
| Drug use and crime: a historical review of research conducted by the UCLA Drug Abuse Research Center | Q40845320 | ||
| Experience of non-fatal overdose among heroin users in Adelaide, Australia: circumstances and risk perceptions | Q40847832 | ||
| Transitions in patterns of heroin administration: a study of heroin chasers and heroin injectors. | Q41040479 | ||
| Mortality from overdose among injecting drug users recently released from prison: database linkage study. | Q42223209 | ||
| Depressive symptoms, drug network, and their synergistic effect on needle-sharing behavior among street injection drug users | Q42595102 | ||
| Factors associated with hepatitis C virus infection in injection and noninjection drug users in Italy | Q42602410 | ||
| A randomised trial of the cost effectiveness of buprenorphine as an alternative to methadone maintenance treatment for heroin dependence in a primary care setting | Q42647130 | ||
| NAOMI--her time has come. North American Opiate Medication Initiative | Q42705071 | ||
| A meta-analysis of predictors of continued drug use during and after treatment for opiate addiction | Q43070954 | ||
| The heroin prescribing debate: integrating science and politics. | Q43592853 | ||
| Differences in severity of heroin dependence by route of administration: the importance of length of heroin use. | Q43620000 | ||
| Potential risk factors for the transition to injecting among non-injecting heroin users: a comparison of former injectors and never injectors | Q43824699 | ||
| Cycling in and out of treatment; participation in methadone treatment in NSW, 1990-2002. | Q43912920 | ||
| Viral hepatitis and other infectious diseases in a homeless population | Q43926303 | ||
| Factors associated with non-fatal heroin overdose: assessing the effect of frequency and route of heroin administration. | Q43966069 | ||
| Canadian illicit opiate users' views on methadone and other opiate prescription treatment: an exploratory qualitative study. | Q44027634 | ||
| A treatment crisis: cocaine use by clients in methadone maintenance programs | Q44066349 | ||
| Chasing the dragon, related to the impaired lung function among heroin users | Q44138261 | ||
| Comparison of buprenorphine and methadone in the treatment of opioid dependence | Q44337404 | ||
| A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence | Q44341599 | ||
| Prevalence of psychiatric and substance use disorders in opioid abusers in a community syringe exchange program. | Q44345227 | ||
| Policy changes and the methadone maintenance treatment system for opioid dependence in Ontario, 1996 to 2001. | Q44348382 | ||
| Factors predicting 2-year retention in methadone maintenance treatment for opioid dependence | Q44348970 | ||
| An overview of illegal opioid use and health services utilization in Canada. | Q44351850 | ||
| Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities | Q44440576 | ||
| Polydrug use and overdose: overthrowing old myths | Q44461366 | ||
| Buprenorphine versus methadone maintenance: a cost-effectiveness analysis | Q44574571 | ||
| Longitudinal Patterns of Drug Injection Behavior in the ALIVE Study Cohort,1988-2000: Description and Determinants | Q44595129 | ||
| Changes in route of drug administration among continuing heroin users: outcomes 1 year after intake to treatment. | Q44965970 | ||
| Accidental overdose among injecting drug users in Dorset, UK. | Q45159185 | ||
| Treating hepatitis C virus infection in active substance users | Q45497739 | ||
| A 24-year follow-up of California narcotics addicts | Q46733329 | ||
| Heroin chasers and heroin injectors: differences observed in a community sample in London, UK. | Q50145828 | ||
| Prevalence of HIV infection and HIV risk behaviors associated with living place: on-the-street homeless drug users as a special target population for public health intervention. | Q50879921 | ||
| Recent contact with health and social services by drug misusers in Glasgow who died of a fatal overdose in 1999. | Q51951806 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | opioid | Q427523 |
| P304 | page(s) | 624-634 | |
| P577 | publication date | 2006-09-01 | |
| P1433 | published in | Canadian Journal of Psychiatry | Q5030253 |
| P1476 | title | Illicit opioid use and its key characteristics: a select overview and evidence from a Canadian multisite cohort of illicit opioid users (OPICAN). | |
| P478 | volume | 51 |
| Q36960510 | A qualitative exploration of prescription opioid injection among street-based drug users in Toronto: behaviours, preferences and drug availability |
| Q30251634 | Benzodiazepine Use, Misuse, and Harm at the Population Level in Canada: A Comprehensive Narrative Review of Data and Developments Since 1995. |
| Q35231536 | Correlates of non-medical prescription drug use among a cohort of injection drug users in Baltimore City |
| Q33579917 | Effect of filtration on morphine and particle content of injections prepared from slow-release oral morphine tablets |
| Q36744335 | Epidemiology of Injection Drug Use: New Trends and Prominent Issues |
| Q36628470 | Evidenced-based treatment of opioid-dependent patients |
| Q34139876 | Genetics of Opioid Dependence: A Review of the Genetic Contribution to Opioid Dependence |
| Q46168285 | Hypertension, chronic obstructive pulmonary disease, diabetes and depression among older methadone maintenance patients in British Columbia |
| Q44332479 | Illicit opioid use and treatment for opioid dependence: challenges for Canada and beyond. |
| Q55001048 | Intolerance of uncertainty and conditioned place preference in opioid addiction. |
| Q92523488 | Investigating opioid-related fatalities in southern Sweden: contact with care-providing authorities and comparison of substances |
| Q33742582 | Methadone deaths: risk factors in pain and addicted populations |
| Q34085814 | Methadone induces testosterone suppression in patients with opioid addiction |
| Q36301817 | Opioid dependence latent structure: two classes with differing severity? |
| Q26778626 | Opioid substitution and antagonist therapy trials exclude the common addiction patient: a systematic review and analysis of eligibility criteria |
| Q47560397 | Poly-Drug Use of Prescription Medicine among People with Opioid Use Disorder in China: A Systematic Review and Meta-Analysis |
| Q34778057 | Prevalence and correlates of nonmedical prescription opioid use among a cohort of sex workers in Vancouver, Canada |
| Q44335166 | Re: Illicit opioid use and its key characteristics: a select overview and evidence from a Canadian multisite cohort of illicit opioid users |
| Q28546840 | Screening and Treatment for Alcohol, Tobacco and Opioid Use Disorders: A Survey of Family Physicians across Ontario |
| Q34312133 | Sex differences amongst dependent heroin users: histories, clinical characteristics and predictors of other substance dependence |
| Q27024389 | Sex differences in outcomes of methadone maintenance treatment for opioid addiction: a systematic review protocol |
| Q127415435 | The Global Diversion of Pharmaceutical Drugs Non‐medical use and diversion of psychotropic prescription drugs in North America: a review of sourcing routes and control measures |
| Q36985312 | The North American Opiate Medication Initiative (NAOMI): profile of participants in North America's first trial of heroin-assisted treatment. |
| Q59793843 | The complex relation between access to opioid agonist therapy and diversion of opioid medications: a case example of large-scale misuse of buprenorphine in the Czech Republic |
| Q37084705 | Type of opioid dependence among patients seeking opioid substitution treatment: are there differences in background and severity of problems? |
| Q26829140 | Update on the clinical use of buprenorphine: in opioid-related disorders |
| Q58151111 | Effet de l'implantation d'une clinique de prescription médicale d'héroïne sur l'environnement communautaire. |
| Q45847009 | Mise à jour sur l’utilisation clinique de la buprénorphine: pour les troubles reliés aux opioïdes |
Search more.